| Director, Biostatistics Hematology | Bristol Myers Squibb | United States | 2026-07-14 |
| Senior Director, BD Japan and Korea | Bristol Myers Squibb | Japan | 2026-07-14 |
| Associate Director, Real World Data Strategy | Bristol Myers Squibb | United States | 2026-07-14 |
| Sr. Director, HRBP - Neurology and Strategy & Innovation | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director, Biostatistics | Bristol Myers Squibb | United States | 2026-07-14 |
| Director, PV Global Process Lead (GPL) | Bristol Myers Squibb | United States | 2026-07-14 |
| Senior Director Oncology Biostatistics | Bristol Myers Squibb | United States | 2026-07-14 |
| Director, Patient Safety Science Capabilities | Bristol Myers Squibb | Madison, United States | 2026-07-14 |
| Associate Director, Customer Insights & Engagement, Melanoma, GU | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| VP, Global Program Lead - Cell Therapy | Bristol Myers Squibb | United States | 2026-07-14 |
| Executive Director, Global Program Lead, Early Development Oncology - Targeted Therapies | Bristol Myers Squibb | United States | 2026-07-14 |
| Associate Director Modeling - Evidence Acceleration & Innovation | Bristol Myers Squibb | United States | 2026-07-14 |
| Executive Director, Global Policy Analytics | Bristol Myers Squibb | United States | 2026-07-14 |
| Associate Director, Congress Engagement | Bristol Myers Squibb | United States | 2026-07-14 |
| Director Data Risk & Protection | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director, Statistical Methodology and Innovation | Bristol Myers Squibb | Uxbridge, United Kingdom | 2026-07-14 |
| Associate Director, GRS Heme/Onc | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Associate Director, Strategy & Media Relations | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Market Access Director | Bristol Myers Squibb | Israel | 2026-07-14 |
| Director, Digitized Case Processing & Device Vigilance | Bristol Myers Squibb | Uxbridge, United Kingdom | 2026-07-14 |
| Director, Digitized Case Processing & Digital Adverse Event Interfaces | Bristol Myers Squibb | United States | 2026-07-14 |
| TAP (Therapeutic Area Partner) | Bristol Myers Squibb | Israel | 2026-07-14 |
| Director, WW Cell Therapy Portfolio, Class Expansion and ST Pipeline | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director, Biostatistical Programming | Bristol Myers Squibb | San Diego, United States | 2026-07-14 |
| Associate Director, CORDS Oncology | Bristol Myers Squibb | United States | 2026-07-14 |
| Director, Program Management, Neuroscience | Bristol Myers Squibb | United States | 2026-07-14 |
| Associate Director, Drug Development Excellence | Bristol Myers Squibb | United States | 2026-07-14 |
| Associate Director, Market Access Strategy & Capability Development | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director, Congress Excellence Strategy Lead | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director of Innovation, Market Access | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director, International Predictive Customer Engagement (IPCE) | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director, Global Operations Transformation | Bristol Myers Squibb | Tampa, United States | 2026-07-14 |
| Senior Director, Portfolio Congress Strategy | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Director, Customer Insights & Engagement- Thoracic | Bristol Myers Squibb | Princeton, United States | 2026-07-14 |
| Head of Utility & Infrastructure Group | Boehringer Ingelheim | Higashine, Japan | 2026-07-14 |
| Responsable Contrรดle publicitรฉ et Conformitรฉ B2B | Novo Nordisk | Puteaux, France | 2026-07-14 |
| Trade-Distributor Partnership Manager-Guangzhou | Sanofi | Guangzhou, China | 2026-07-14 |
| Associate Director, Strategic Pricing | Sanofi | France | 2026-07-14 |
| Head of Distribution South Korea (์๋ช
๊ณผํ, Chemical) | Merck KGaA | Incheon, South Korea | 2026-07-14 |
| Chief of Staff to TIB Molbiol CEO & Head of Strategic Execution (m/w/d) | Roche | Berlin, Germany | 2026-07-14 |
| ๆฒป็้ขๅ็ป็ - ่กๆถฒๆฒป็้ขๅ - ๆญๅท | Roche | Hangzhou, China | 2026-07-14 |
| (้ซ็บง๏ผไบงๅ็ป็ - ่กๆถฒ่ฟ็คๆฒป็้ขๅ | Roche | Shanghai, China | 2026-07-14 |
| Patient Journey Partner - Ophthalmology | Roche | Switzerland | 2026-07-14 |
| Patient Journey Partner- Opthalmology | Roche | Switzerland | 2026-07-14 |
| Surgical Device Partner | Roche | Spain | 2026-07-14 |
| Agentic Innovation Partner (RDT Data & AI) | Roche | Switzerland | 2026-07-14 |
| ไธไธๅฎขๆท็ป็-่บ็-้ๅท | Johnson & Johnson | Zhengzhou, China | 2026-07-14 |
| ไธไธๅฎขๆท็ป็-่บ็-ๆทฑๅณ | Johnson & Johnson | Shenzhen, China | 2026-07-14 |
| ๏ผ้ซ็บง๏ผๅฐๅบ็ป็-็ฎ็งไบงๅไธๅก้จ-ๅไบฌ | Johnson & Johnson | Beijing, China | 2026-07-14 |
| ไธไธๆ่ฒ็ป็ | Johnson & Johnson | Shanghai, China | 2026-07-14 |